Efficacy News and Research

RSS
New gene therapy addresses primary cellular deficit associated with limb-girdle muscular dystrophy 2B

New gene therapy addresses primary cellular deficit associated with limb-girdle muscular dystrophy 2B

Research demonstrates the safety, feasibility of psilocybin administered at doses of 10mg or 25mg

Research demonstrates the safety, feasibility of psilocybin administered at doses of 10mg or 25mg

Experts cautiously optimistic about risks of Delta-Omicron mutations mix

Experts cautiously optimistic about risks of Delta-Omicron mutations mix

SARS-CoV-2 mRNA vaccine boosters crucial in maintaining neutralizing antibodies in HCPs

SARS-CoV-2 mRNA vaccine boosters crucial in maintaining neutralizing antibodies in HCPs

Quitting smoking at or around diagnosis improves survival of lung cancer patients

Quitting smoking at or around diagnosis improves survival of lung cancer patients

Israeli study confirms drop in BNT162b2 efficacy after six months

Israeli study confirms drop in BNT162b2 efficacy after six months

A closer look at the relationship between COVID-19 and Alzheimer’s disease

A closer look at the relationship between COVID-19 and Alzheimer’s disease

Efficacy of antibodies induced by natural infection, vaccination, or both against SARS-CoV-2 Omicron and Beta variants

Efficacy of antibodies induced by natural infection, vaccination, or both against SARS-CoV-2 Omicron and Beta variants

In vitro effect of several antiviral drugs against various SARS-CoV-2 variants of concern

In vitro effect of several antiviral drugs against various SARS-CoV-2 variants of concern

The impact of natural selection on sequence diversity in SARS-CoV-2

The impact of natural selection on sequence diversity in SARS-CoV-2

Researchers identify a biomarker in platelets that tracks the extent of depression

Researchers identify a biomarker in platelets that tracks the extent of depression

Humanized antibody shows strong neutralization ability against SARS-CoV-2 Delta variant

Humanized antibody shows strong neutralization ability against SARS-CoV-2 Delta variant

SARS-CoV-2 Omicron study on hamsters, shows virus results in a less severe disease

SARS-CoV-2 Omicron study on hamsters, shows virus results in a less severe disease

Omicron surges in England especially in young

Omicron surges in England especially in young

Echinacea, a potent antiviral against SARS-CoV-2

Echinacea, a potent antiviral against SARS-CoV-2

Genomic variant may help predict which patients will experience chemotherapy-induced cardiotoxicity

Genomic variant may help predict which patients will experience chemotherapy-induced cardiotoxicity

New systematic review finds low-quality evidence on the effectiveness of hangover remedies

New systematic review finds low-quality evidence on the effectiveness of hangover remedies

Engineer receives $2.1 million grant to test a treatment strategy for children with cerebral palsy

Engineer receives $2.1 million grant to test a treatment strategy for children with cerebral palsy

WHO lists the Comirnaty COVID-19 mRNA vaccine for emergency use

WHO lists the Comirnaty COVID-19 mRNA vaccine for emergency use

Impact of a pan-sarbecovirus dendritic-cell targeting vaccine on SARS-CoV-2 variants

Impact of a pan-sarbecovirus dendritic-cell targeting vaccine on SARS-CoV-2 variants

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.